Bleeding and thrombotic risks for prosthetic heart valves: A review of the principles of management

Cardiovascular Reviews and Reports

Volumn 21, Issue 9, 2000, Pages 475-480

  Petrasko, M S ^a   Sadaniantz, A ^a  

^a MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DIGOXIN; FUROSEMIDE; PARACETAMOL; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG WITHDRAWAL; EMBOLISM; HEADACHE; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HUMAN; MALE; POSTOPERATIVE COMPLICATION; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0034426729     PISSN: 01973118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range
2. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves
3. Guidelines for prevention of thromboembolic events in valvular heart disease
4. Aiming for safe anticoagulation
5. Hemorrhagic complications of anticoagulant treatment
6. Anticoagulant-related intracerebral hemorrhage
7. Double trouble: A patient with two prosthetic valves and two episodes of intracranial bleeding
8. Risk factors for complications of chronic anticoagulation. A multicenter study
9. Cerebrovascular accidents in patients receiving anticoagulant drugs
10. The relationship of subdural hematoma to anticoagulant therapy
11. Neurosurgical complications of anticoagulation therapy
12. Intracranial hemorrhage associated with anticoagulation therapy
13. Intracranial hemorrhage and infarction in anticoagulated patients with prosthetic heart valves
14. Neurological complications of anticoagulation therapy
15. Trial of different intensities of anticoagulation in patients with prosthetic heart valves
16. Comparison of two levels of anticoagulant therapy in patients with prosthetic heart valves
17. Optimal oral anticoagulant therapy in patients with mechanical heart valves
18. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis
19. Randomized comparison of two intensities of oral anticoagulant therapy after tissue heart replacement
20. Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of out patient therapy
21. Hemorrhagic complications of anticoagulant therapy
22. Duration of warfarin anticoagulation therapy and the probabilities of recurrent thrombosis and hemorrhage
23. Bleeding complications in anticoagulant therapy: Multivariate analysis of 1010 treatment outpatients
24. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors
25. Management of anticoagulation in outpatients: Experience with an anticoagulation service in a municipal hospital setting
26. A 7 year analysis of hemorrhage in patients on long-term anticoagulant treatment
27. Age-related risks of long-term oral anticoagulant therapy
28. Bleeding and thromboembolism during anticoagulant therapy: A population-based study in Rochester, Minnesota
29. The significance of hemorrhage during treatment of patients with coumadin anticoagulants
30. Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement
31. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: Danger of aspirin compared with dipyridamole
32. Reduction in mortality by adding aspirin (100 mg) to oral anticoagulants in patients with heart replacement
33. Thrombotic and bleeding complications of prosthetic heart valves
34. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses
35. Adjusting anticoagulation to prosthesis thrombogenicity and patient risk factors. Recommendations for the Medtronic Hall valve
36. Resumption of anticoagulation during hypertensive cerebral hemorrhage with prosthetic heart valve
37. Resumption of anticoagulation after intracranial bleeding in patients with prosthetic heart valves
38. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic
39. Prospective comparative study of computer programs used for management of warfarin